How to Cite
Abstract
Background: Anemia is the most frequent haematological problem in pregnancy, followed by thrombocytopenia. Thrombocytopenia complicates about 8% of pregnancies, with the majority of these cases occurring in the third trimester.
Objective: To find out whether pregnant women with mild, moderate, or severe thrombocytopenia had a better pregnancy outcome.
Materials And Methods: A descriptive research was carried out at Benazir Bhutto Hospital in Rawalpindi's Department of Obstetrics and Gynecology. All pregnant women in the study had a full blood count done. The research comprised 116 women with a platelet count below 150 103/L. A manual platelet count was used to validate the results. The ladies were split into three groups based on their platelet counts. Blood tests are performed on each member of the first group to determine their platelet count (MILD). People in Group 2 have a platelet count of 50-100 x103/ul (MODERATE). Platelet count of 50 x103/L in the third group (SEVERE). There was a fetal-maternal result. Postpartum haemorrhage, method of delivery, requirement for platelet transfusion, and maternal death were all considered maternal outcomes. Baby's weight, Apgar score, and admission to the Neonatal Intensive Care Unit were documented as foetal outcomes.
Results: Most of the women in my research were between the ages of 26 and 35. (57 percent ). The population's median age was 29 years. The platelet count ranged from 32000 to 149000/L, with a mean of 109 x 103/L. Mild thrombocytopenia was seen in the majority of female patients in this study (64). In the current research, gestational thrombocytopenia accounted for 72 percent of instances of thrombocytopenia in pregnancy, with hypertension complicating pregnancy accounting for 15 percent of cases. One percent of patients had HELLP. Ten percent (12) of the women required platelet transfusion. Ninety-four percent of the women delivered by caesarean section, while the remaining six percent did it vaginally. Only maternal and obstetric reasons dictated the delivery method. Only one percent of the babies in our research had to be admitted to the neonatal intensive care unit, and 25 percent of the babies were too tiny for their gestational age.
Conclusion: However, in life-threatening situations like as HELLP syndrome, treating an expectant mother with severe thrombocytopenia may be difficult. When a woman's pregnancy is at high risk, close monitoring is necessary to catch problems early and provide her the care she needs quickly. This will help the baby and the mother live healthier lives. Due to its lack of connection to an unfavourable pregnancy outcome, gestational thrombocytopenia may be considered a benign disease.
Keywords: Thrombocytopenia, Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, HELLP syndrome.